Revvity: A Diagnostics Annuity Is Quietly Funding An AI Data Engine
Revvity’s diagnostics revenue grew 11% and software ARR rose mid-20%, funding an AI-enabled platform despite life sciences weakness.
Equity Eagle 1 clickNYSE
Revvity, INC.
RVTY $18B
Cap as of Nov 11 1 story
Get RVTY news in Claude, ChatGPT or your own code. See plans
Equity Eagle 1 clickInvestor Letters
Letters that discuss RVTY.
- Victory Capital — Sycamore Mid Cap Value Equity Sycamore Mid Cap Value Equity Quarterly Commentary third quarter of 2026 CACI $14BCMS $22BFIS $16B
- EdgePoint Wealth Management Why did your cash balance almost hit 2.5% despite the market being near all-time highs? 2nd quarter, 2026 RVTY $18BSPGI $138BTCTZF $470B
- EdgePoint Wealth Management Dropping the (crystal) ball 4th quarter, 2024 SAP $270B
